Indefinite Delivery Contract FA865014D6516

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...

The National Institutes of Health National Cancer Institute awarded a single award indefinite delivery contract to Olink Proteomics AB to procure protein biomarker analysis services. Task orders issued to date against the contract include immuno-oncology, inflammation, and pediatric oncology analysis services using Olink's proprietary multiplex platforms. Services are being performed in various locations including Massachusetts, Maryland, and the District of Columbia through July 2024....

The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...

The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Cedars-Sinai Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. With a potential value of $500 million, this IDV enables task orders to be placed through September 2033 for complex data analysis, integration and management of large-scale genomic and health datasets to support the initiative's goals. The originating pre-solicitation...

This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The $49.8 million IDC supports the NCI Genomic Characterization Centers and provides comprehensive genomic sequencing, data analysis, and other advanced computational biology services to NCI institutes and centers. Under the IDC, The Broad Institute has been awarded multiple task...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently...

The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract to the University of Washington with a potential value of $500 million. The contract provides for Centralized Omics Resource DNA methylation services to support the Trans-Omics for Precision Medicine initiative through September 2033. A firm fixed price delivery order for $2.99 million was issued against this contract to...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Vanderbilt University Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. This IDV has a potential value of $500 million and a period of performance through September 2033. The purpose of the contract is to provide complex data analysis, integration, and management of large-scale genomic and health datasets to support the Trans-Omics...